chemical

ML 315 hydrochloride

5700/10

10 mg (also 50 mg)

196 USD

5700

5700/10

ML 315 hydrochloride

Inhibitor of Clk and DYRK kinases

Cdc2-like Kinase Inhibitors

10 mg (also 50 mg)

Small Molecules

98%

Store at -20°C

410.68

?utm_source=biocompare&utm_medium=referral&utm_campaign=product&utm_term=smallmolecules

ML 315 hydrochloride is a inhibitor of cdc2-like kinases (Clk) and DYRK kinases (IC50 values are 68, 68 and 231 nM for Clk1, Clk4 and Clk2, respectively, and 282 and 1156 nM for Dyrk1A and Dyrk1B). Shows 20-fold selectivity for Clk4 over Dyrk1A. Stable in both mouse and human plasma. Moderately cell permeable.

ML315 HCl Inhibitors Inhibits Cdc2-like kinases Clk kinase Dual specificity tyrosine phosphorylation-regulated kinases DYRK kinase CLK (Cdc2-like kinases) DYRK 5700,

Inhibitor of Clk and DYRK kinases

5-(1,3-Benzodioxol-5-yl)-N-[(3,5-dichlorophenyl)methyl]-4-pyrimidinamine hydrochloride

C18H13Cl2N3O2.HCl

C18H13Cl2N3O2.HCl

1440251-53-5

217

196 USD

Inhibitor of Clk and DYRK kinases